» Articles » PMID: 15075227

Role of Tau Phosphorylation by Glycogen Synthase Kinase-3beta in the Regulation of Organelle Transport

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2004 Apr 13
PMID 15075227
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Anterograde organelle transport is known to be inhibited by overexpression of the microtubule-associated protein tau in cultured cells. However, the molecular mechanism regulating this function of tau protein has not previously been understood. We found that in PC12 cells treated with NGF or fibroblast growth factor-2, glycogen synthase kinase-3beta and tau were upregulated simultaneously from around day 2 of differentiation, with increasing glycogen synthase kinase-3-mediated tau phosphorylation. This phosphorylation did not alter tau's ability to bind to microtubules but appeared to be required for the maintenance of the anterograde organelle transport in differentiated cells. Lithium, alsterpaullone or valproate, three independent glycogen synthase kinase-3 inhibitors, but not butyrolactone 1, an inhibitor of cyclin-dependent protein kinases, induced mitochondrial clustering in association with tau dephosphorylation. In CHO cells transfected with human tau(441), mitochondrial clustering was found in cells in which tau was unphosphorylated. These findings raise the possibility that the phosphorylation of tau by glycogen synthase kinase-3 might be involved in the regulation of organelle transport.

Citing Articles

Differential Regulation of Neurotrophic Factors During Pathogenic Tau-Aggregation in a Tau Transgenic Mouse Model for Alzheimer's Disease: A Protocol for Double-Labeling mRNA by In Situ Hybridization and Protein Epitopes by Immunohistochemistry.

Schindowski K Methods Mol Biol. 2024; 2754:361-385.

PMID: 38512677 DOI: 10.1007/978-1-0716-3629-9_20.


Correlation analysis between the amniotic fluid contamination and clinical grading of neonatal hypoxic-ischemic encephalopathy and biomarkers of brain damage.

Lv H, Liu F, Wang Q, Dong Z, Zhang H, Ren P BMC Pediatr. 2024; 24(1):178.

PMID: 38481189 PMC: 10935862. DOI: 10.1186/s12887-024-04663-9.


Polyherbal and Multimodal Treatments: Kaempferol- and Quercetin-Rich Herbs Alleviate Symptoms of Alzheimer's Disease.

Alexander C, Parsaee A, Vasefi M Biology (Basel). 2023; 12(11).

PMID: 37998052 PMC: 10669725. DOI: 10.3390/biology12111453.


Revisiting the Role of GSK3, A Modulator of Innate Immunity, in Idiopathic Inclusion Body Myositis.

Piazzi M, Bavelloni A, Cenni V, Faenza I, Blalock W Cells. 2021; 10(11).

PMID: 34831477 PMC: 8625526. DOI: 10.3390/cells10113255.


Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration.

Giunta M, Solje E, Gardoni F, Borroni B, Benussi A J Exp Pharmacol. 2021; 13:359-376.

PMID: 33790662 PMC: 8005747. DOI: 10.2147/JEP.S262352.